Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Prospective Study for Evaluation of the Insulin Resistance, Lipid Metabolism and Sub Clinical Cardiovascular Disease in Women Who Initiate the Depot-medroxyprogesterone Acetate (DMPA) Contraceptive Method With in Follow-up for Two Years
Brief Summary: Objective:

The purpose of this study is to determine the etiology of the weight increase in Depot-medroxyprogesterone Acetate (DMPA) users.

Method:

Prospective study with 100 women, aged 18-40 years old and BMI \< 30kg/m², paired with users of a non hormonal method follow for two years. Will be included only women who never used DMPA. There will be evaluated habit, blood pressure, anthropometric measure, distribution of corporal fat, lipids profile and glycemia parameters every six months. Thirty women and their control group will performed a euglycemic-hyperinsulinemic clamp to evaluate the resistance of insulin, adiponectin,neuropeptide Y, apolipoprotein A/B and arterial evaluation with ultrasound, intimal and media measure. Anova analysis for repeated samples. The metabolic alterations should elucidate the etiology, and the beginning of the sub clinical cardiovascular disease should be shown/discarded with the arterial evaluation.


Options:
A: N/A
B: Arm Label: Immediate implant; Type: EXPERIMENTAL; Interventions: Device: Sino-implant (II) | Arm Label: Delayed implant; Type: ACTIVE_COMPARATOR; Interventions: Device: Sino-implant (II) | Intervention Type: DEVICE; Name: Sino-implant (II); Assigned to Arm(s): Delayed implant, Immediate implant
C: Arm Label: copper intrauterine device; Type: ACTIVE_COMPARATOR; Interventions: Device: copper-releasing intrauterine device, Device: ENG-releasing implant, Device: LNG-releasing intrauterine system, Device: LNG-IUS | Arm Label: LNG-releasing intrauterine system; Type: ACTIVE_COMPARATOR; Interventions: Device: ENG-releasing implant, Device: LNG-releasing intrauterine system, Device: LNG-IUS | Arm Label: ENG-releasing implant; Type: ACTIVE_COMPARATOR; Interventions: Device: ENG-releasing implant, Device: LNG-releasing intrauterine system, Device: LNG-IUS | Intervention Type: DEVICE; Name: copper-releasing intrauterine device; Assigned to Arm(s): copper intrauterine device | Intervention Type: DEVICE; Name: ENG-releasing implant; Assigned to Arm(s): ENG-releasing implant, LNG-releasing intrauterine system, copper intrauterine device | Intervention Type: DEVICE; Name: LNG-releasing intrauterine system; Assigned to Arm(s): ENG-releasing implant, LNG-releasing intrauterine system, copper intrauterine device | Intervention Type: DEVICE; Name: LNG-IUS; Assigned to Arm(s): ENG-releasing implant, LNG-releasing intrauterine system, copper intrauterine device
D: Arm Label: All participants; Type: OTHER; Interventions: Drug: All participants (Aviane) | Arm Label: Aviane and Portia; Type: ACTIVE_COMPARATOR; Interventions: Drug: Portia | Arm Label: Aviane & Aviane; Type: ACTIVE_COMPARATOR; Interventions: Drug: Aviane | Intervention Type: DRUG; Name: All participants (Aviane); Assigned to Arm(s): All participants | Intervention Type: DRUG; Name: Portia; Assigned to Arm(s): Aviane and Portia | Intervention Type: DRUG; Name: Aviane; Assigned to Arm(s): Aviane & Aviane

Answer: A